PLoS ONE (Jan 2023)

A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis.

  • Xuecheng Li,
  • Yi Lu,
  • Xiaoshuang Liang,
  • Xiaofei Zhou,
  • Dirui Li,
  • Zan Zhang,
  • Yunchao Niu,
  • Shuaishuai Liu,
  • Ling Ye,
  • Rufeng Zhang

DOI
https://doi.org/10.1371/journal.pone.0286257
Journal volume & issue
Vol. 18, no. 5
p. e0286257

Abstract

Read online

Non-alcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, with a significant proportion of patients progressing into non-alcoholic steatohepatitis (NASH) and further into cirrhosis and hepatocellular carcinoma (HCC). Most of the current animal models of NASH have limitations, such as incompatibility with human pathogenesis characteristics or long induction periods, which severely limit the development of new drugs and preclinical studies for NASH. We investigated the progression of NASH and fibrosis, as well as metabolic indicators, at different time points in aged mice induced by the Gubra Amylin NASH (GAN) diet, a high-fat, high-sugar, high-cholesterol diet, and attempted to establish a rapid and useful mouse model of NASH. Young and aged C57BL/6 mice were induced on a normal chow or GAN diet for 12 and 21 weeks, respectively. After 12 weeks of induction, aged mice developed NASH, including hepatic steatosis, lobular inflammation and hepatic ballooning, and the phenotype was more severe compared with young mice. After 21 weeks of induction, aged mice developed hepatic fibrosis, which greatly shortened the induction time compared with young mice. Furthermore, analysis of immune cell infiltration in the liver by flow cytometry elucidated the changes of multiple immune cells during the pathogenesis of NASH. These findings suggest that aged mice may develop NASH and fibrosis more rapidly under GAN diet induction, which may significantly shorten the period for preclinical studies of NASH.